We are live on ! Find out more
PPHMP

Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible
PPHMP

Delisted

PPHMP was delisted on the 5th of January, 2018.

Back to rankings

1 hedge funds and large institutions have $10K invested in Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

9% less capital invested

Capital invested by funds: $11K → $10K (-$1K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BWA
1
Burt Wealth Advisors
Maryland
$10K – – –

PPHMP Hedge Fund Activity: Q2 2016 in Review

1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible (PPHMP) for Q2 2016, worth a combined $10K — down 9.1% from $11K a quarter earlier.

Fund positioning in PPHMP was balanced in Q2 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible (PPHMP) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $10K of Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible stock for Q2 2016, down 9.1% quarter-over-quarter.
  • 0 funds opened new Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible positions in Q2 2016 and 0 closed out.

Based on aggregated 13F filings for Q2 2016.